Evidence map›Paper›PMID 39403169›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2024

In vivo and in vitro Models of PM2.5 Induced COPD: Focus on the Role of RTA-408.

Yibing Niu, Ling Zhang, Sumin Guo, Shucai Wu

Abstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yibing NiuDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Ling ZhangDepartment of Respiratory, Hebei Chest Hospital, Shijiazhuang, Hebei, People's Republic of China.
Sumin GuoDepartment of Oncology, Hebei Chest Hospital, Shijiazhuang, Hebei, People's Republic of China.
Shucai WuDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.

Funding

Provincial Major Health Project of Hebei Province 0012
6 · The paper itself

Abstract

Introduction: Inflammation and oxidative stress are important factors in the pathogenesis of Chronic obstructive pulmonary disease (COPD). Current treatments for COPD focus on improving symptoms caused by inflammation rather than curing the disease, therefore, emerging research focusing on upstream pathways may help develop effective treatments. Epidemiological investigations have shown that exposure to fine particulate matter (PM2.5) can cause lung inflammation and oxidative stress through nuclear factor NF-E2-associated factor (Nrf2) pathway, leading to COPD. Nrf2 is an important transcription factor regulating anti-inflammatory and antioxidant stress, and its abnormal expression level or changes in transcriptional activity are related to the occurrence and development of COPD. Omaviloxone - RTA-408, a synthetic oleanane triterpene that acts as an Nrf2 activator, RTA-408 may play an important role in COPD. Purpose: In this study, PM2.5 was used to establish HBE cell model in vitro and rat model in vivo to simulate COPD, and the effect of Nrf2 activator RTA-408 on PM2.5-induced COPD model and its mechanism were investigated. Patients and Methods: The HBE cell model in vitro and rat model in vivo were established to simulate COPD, and the effect of RTA-408 on COPD was detected by various experimental methods. Results: The results showed that RTA-408 could activate Nrf2 both in vivo and in vitro. By activating Nrf2/HO-1 pathway, RTA-408 inhibits NF-κB and IFN-γ pathways, alleviates inflammation and oxidative stress of HBE cells in COPD model rats and PM2.5 exposed cells, and plays a therapeutic role in reversing cell damage and delaying disease progression in COPD. In addition, in vitro experiments, silencing Nrf2 eliminated the protective effect of RTA-408 on COPD cell models, which also confirmed the role of RTA-408. Conclusion: We conclude that RTA-408 is well worth considering as a new strategy for the treatment of COPD, and may also have a positive preventive effect.

Indexed as

Disease Models, AnimalLungNF-E2-Related Factor 2Oxidative StressParticulate MatterPulmonary Disease, Chronic ObstructiveSignal TransductionAnimalsAnti-Inflammatory AgentsBronchiCell LineEpithelial CellsHeme Oxygenase-1Heme Oxygenase (Decyclizing)HumansInflammation MediatorsAnti-Inflammatory AgentsHeme Oxygenase-1Heme Oxygenase (Decyclizing)HMOX1 protein, humanHmox1 protein, ratInflammation MediatorsNFE2L2 protein, humanNfe2l2 protein, ratNF-E2-Related Factor 2NF-kappa BOleanolic AcidomaveloxoloneParticulate MatterTriterpeneschronic obstructive pulmonary diseaseinflammationNrf2oxidative stressRTA-408

Identifiers

PMID39403169
PMCPMC11471910

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.